Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men
Canadian Diabetes & Endocrinology Today · 2024
DOI: 10.58931/cdet.2024.2330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Diabetes & Endocrinology Today, 2024. Verfasst von Jagoda Kissock. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Testosterone replacement therapy (TRT) aims to restore serum testosterone levels in men with hypogonadism. Symptoms associated with hypogonadism include reduced libido, erectile dysfunction, fatigue, depression, and loss of muscle mass and bone density. The primary purpose of TRT is to alleviate these symptoms and improve quality of life by restoring serum testosterone levels to the physiological range. The prevalence of hypogonadism in men increases with age, affecting approximately 2–5% of middle-aged and older men and up to 20% of elderly men. Despite its therapeutic benefits, the cardiovascular safety of TRT remains a topic of debate and investigation. Cardiovascular disease is a leading cause of morbidity and mortality among men, and any therapy that might influence cardiovascular risk requires careful evaluation. Early observational studies raised concerns about potential adverse cardiovascular outcomes associated with TRT. These findings prompted regulatory agencies to issue warnings and recommend further research. In response, more recent trials, including the TRAVERSE Study, have provided new insights into the relationship between TRT and cardiovascular health. This article aims to provide a review of recent evidence on the cardiovascular safety of TRT.
Zitieren
APA
Kissock, J. (2024). Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men. Canadian Diabetes & Endocrinology Today. https://doi.org/10.58931/cdet.2024.2330
Vancouver
Kissock J. Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men. Canadian Diabetes & Endocrinology Today. 2024. doi:10.58931/cdet.2024.2330
BibTeX
@article{Kissock2024,
author = {Kissock, Jagoda},
title = {Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men},
journal = {Canadian Diabetes & Endocrinology Today},
year = {2024},
doi = {10.58931/cdet.2024.2330}
}
EUVIMED